Dr Giles Campion describes an investigational siRNA therapy designed to reduce cardiovascular risk in people with elevated Lp(a).
Dr Giles Campion describes an investigational siRNA therapy designed to reduce cardiovascular risk in people with elevated Lp(a).
Exciting progress